secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001193125-24-004833
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics posts updated corporate presentation; no specific new financial or operational data disclosed
--------------------------------------------------------------------------------

- Company filed an 8-K on Jan 9, 2024 to disclose an updated corporate presentation.
- Presentation posted on Seres' investor relations website; no financial results or guidance provided.
- Exhibit 99.1 text truncated; full presentation content not available for review.
- Filing is a routine Regulation FD disclosure with no material new information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524004833/0001193125-24-004833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524004833/d90190d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-004833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer